Overview

Application of 68Ga-DOTA-TATE and 68Ga-DOTA-JR11 PET/CT in the Diagnosis and Evaluation of TIO

Status:
Recruiting

Trial end date:
2022-03-15

Target enrollment:

Participant gender:

Summary

This is an open-label whole-body PET/CT study for investigating the value of 68Ga-DOTA-TATE and 68Ga-DOTA-JR11 PET/CT in patients with Tumor-induced osteomalacia.

Phase:

Phase 1

Details

Lead Sponsor:

Peking Union Medical College Hospital

Treatments:

1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid